Hypophosphatasia synonyms

Hypophosphatasia (HPP) is a rare genetic metabolic bone disease primarily known by its scientific name, though it is occasionally referred to as "phosphoethanolaminuria" in older clinical literature. While there are no widely used clinical synonyms today, the condition is categorized by its age of onset (e.g., perinatal, infantile, childhood, or adult HPP) to better describe the specific clinical presentation.

What are the official names and classifications for Hypophosphatasia?

In modern medical practice, Hypophosphatasia is the internationally recognized name for this disorder, which is characterized by defective bone mineralization due to low levels of alkaline phosphatase (ALP). In official medical coding systems, it is classified under the following identifiers:

• OMIM (Online Mendelian Inheritance in Man): #146300 (perinatally lethal), #241500 (infantile), #241510 (childhood), #146300 (adult).


• Orphanet: ORPHA436.


• ICD-10: E83.31 (Hypophosphatasia).

Why does Hypophosphatasia have different descriptive names?

Historically, the condition was sometimes referred to as "phosphoethanolaminuria," named after the excessive excretion of phosphoethanolamine in the urine, which was one of the first biochemical markers identified for the disease. However, as our understanding of the underlying genetic mutation in the ALPL gene evolved, the medical community shifted to the more descriptive term Hypophosphatasia. This name directly references the "hypo" (low) levels of "phosphatase" (the alkaline phosphatase enzyme) activity. Unlike many other rare diseases, Hypophosphatasia is rarely referred to by an eponym (a name derived from a person), which helps reduce confusion in medical documentation.

How is the condition categorized in medical literature?

Because the clinical severity of Hypophosphatasia varies significantly between patients, medical professionals often categorize the disease based on the age at which symptoms first appear. This is not a formal name change, but rather a clinical sub-classification used to guide treatment and prognosis. The six recognized clinical forms include:

1. Perinatal (the most severe form)


2. Benign prenatal


3. Infantile


4. Childhood


5. Adult


6. Odontohypophosphatasia (a milder form primarily affecting the teeth)

Which name should patients use when speaking with specialists?

When communicating with your healthcare team, always use the term Hypophosphatasia. This ensures that your medical records are correctly linked to current clinical guidelines and therapeutic protocols, such as enzyme replacement therapy. Using the standard name is crucial for insurance authorization, referral to metabolic specialists, and accessing specialized care protocols designed for patients with Hypophosphatasia. Avoid using outdated terms like "phosphoethanolaminuria" in modern clinical settings to prevent any confusion regarding your diagnosis.

Next steps

• Consult with a metabolic geneticist or an endocrinologist who specializes in bone health.


• Ensure your medical records consistently list Hypophosphatasia and the specific clinical form (e.g., adult or childhood) for accurate tracking.


• Connect with the 9 members of the DiseaseMaps community to share experiences and coping strategies.


• Visit the NIH GARD website to stay updated on the latest research and clinical trial opportunities.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

References

• NIH GARD (Genetic and Rare Diseases Information Center): https://rarediseases.info.nih.gov/diseases/6661/hypophosphatasia


• Orphanet: https://www.orpha.net/en/disease/detail/436


• OMIM: https://www.omim.org/entry/146300


• The Hypophosphatasia Association: https://www.hpp-hsa.org/